The use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent years, with 12% of U.S. adults having used one despite the high cost, according to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback